NO20082547L - Orale formuleringer omfattende tigecycline - Google Patents
Orale formuleringer omfattende tigecyclineInfo
- Publication number
- NO20082547L NO20082547L NO20082547A NO20082547A NO20082547L NO 20082547 L NO20082547 L NO 20082547L NO 20082547 A NO20082547 A NO 20082547A NO 20082547 A NO20082547 A NO 20082547A NO 20082547 L NO20082547 L NO 20082547L
- Authority
- NO
- Norway
- Prior art keywords
- tigecycline
- oral formulations
- mixture
- disclosed
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Det beskrives farmasøytiske blandinger som omfatter tigecyklin for peroral administrering. Blandingen kan omfatte tigecyklin som har minst én enterodrasjering.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75303505P | 2005-12-22 | 2005-12-22 | |
PCT/US2006/048621 WO2007075794A2 (en) | 2005-12-22 | 2006-12-20 | Oral formulations comprising tigecycline |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082547L true NO20082547L (no) | 2008-09-22 |
Family
ID=37964562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082547A NO20082547L (no) | 2005-12-22 | 2008-05-30 | Orale formuleringer omfattende tigecycline |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080014256A1 (no) |
EP (1) | EP1965770A2 (no) |
KR (1) | KR20080080205A (no) |
CN (1) | CN101340895A (no) |
AU (1) | AU2006331688A1 (no) |
BR (1) | BRPI0620646A2 (no) |
CA (1) | CA2632213A1 (no) |
CR (1) | CR10124A (no) |
EC (1) | ECSP088635A (no) |
GT (1) | GT200800107A (no) |
IL (1) | IL191789A0 (no) |
NO (1) | NO20082547L (no) |
RU (1) | RU2008120672A (no) |
WO (1) | WO2007075794A2 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006084058A2 (en) | 2005-02-03 | 2006-08-10 | The General Hospital Corporation | Method for treating gefitinib resistant cancer |
BRPI0618042A2 (pt) | 2005-11-04 | 2011-08-16 | Wyeth Corp | usos de uma rapamicina e de uma herceptina, produto, pacote farmacêutico, e, composição farmacêutica |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
US9107929B2 (en) | 2008-05-01 | 2015-08-18 | Ranbaxy Laboratories Limited | Stable parenteral formulations of tigecycline |
ES2958968T3 (es) | 2008-06-17 | 2024-02-16 | Wyeth Llc | Combinaciones antineoplásicas que contienen HKI-272 y vinorelbina |
SI2326329T1 (sl) | 2008-08-04 | 2017-06-30 | Wyeth Llc | Antineoplastične kombinacije 4-anilino-3-cianakinolinov in kapecitabina |
WO2010117633A1 (en) | 2009-04-06 | 2010-10-14 | Wyeth Llc | Treatment regimen utilizing neratinib for breast cancer |
EP2498751B1 (en) * | 2009-11-09 | 2019-04-03 | Wyeth LLC | Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
AU2011252919B2 (en) | 2010-05-12 | 2017-01-19 | Melinta Therapeutics, Inc. | Tetracycline compositions |
KR102294577B1 (ko) * | 2015-01-12 | 2021-08-26 | 엔터리스 바이오파마, 인크. | 고체 경구 제형 |
WO2019139877A1 (en) * | 2018-01-10 | 2019-07-18 | The University Of North Carolina At Chapel Hill | Tigecycline for topical treatment of root canal space |
CN111166729A (zh) * | 2020-03-19 | 2020-05-19 | 珠海赛隆药业股份有限公司 | 一种口服的替加环素肠溶微球及其制备方法 |
CN112577917A (zh) * | 2020-12-28 | 2021-03-30 | 瀚晖制药有限公司 | 注射用替加环素中有色杂质的检测方法 |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3026248A (en) * | 1959-09-11 | 1962-03-20 | Pfizer & Co C | Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents |
US3219529A (en) * | 1962-10-04 | 1965-11-23 | American Cyanamid Co | Stable tetracycline solutions |
US4837030A (en) * | 1987-10-06 | 1989-06-06 | American Cyanamid Company | Novel controlled release formulations of tetracycline compounds |
US5494903A (en) * | 1991-10-04 | 1996-02-27 | American Cyanamid Company | 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
US5281628A (en) * | 1991-10-04 | 1994-01-25 | American Cyanamid Company | 9-amino-7-(substituted)-6-demethyl-6-deoxytetracyclines |
US5167964A (en) * | 1992-02-14 | 1992-12-01 | Warner-Lambert Company | Semi-enteric drug delivery systems and methods for preparing same |
US5328902A (en) * | 1992-08-13 | 1994-07-12 | American Cyanamid Co. | 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
US5420272A (en) * | 1992-08-13 | 1995-05-30 | American Cyanamid Company | 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
SG47520A1 (en) * | 1992-08-13 | 1998-04-17 | American Cyanamid Co | New method for the production of 9-amino-6-demethyl-6-deoxytetracycline |
WO1995022529A1 (en) * | 1994-02-17 | 1995-08-24 | Pfizer Inc. | 9-(substituted amino)-alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics |
US5567693A (en) * | 1994-12-13 | 1996-10-22 | American Cyanamid Company | Method for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growth |
US6063775A (en) * | 1997-04-29 | 2000-05-16 | Berman; Charles L. | Retardation of metalloproteinase incidental to HIV and/or AIDS |
US5908838A (en) * | 1998-02-19 | 1999-06-01 | Medics Pharmaceutical Corporation | Method for the treatment of acne |
US6015803A (en) * | 1998-05-04 | 2000-01-18 | Wirostko; Emil | Antibiotic treatment of age-related macular degeneration |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
US6506740B1 (en) * | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
KR20030007489A (ko) * | 2000-03-31 | 2003-01-23 | 트러스티즈 오브 터프츠 칼리지 | 7- 및 9-카르바메이트, 우레아, 티오우레아,티오카르바메이트 및 헤테로아릴-아미노 치환된테트라사이클린 화합물 |
BR0112265A (pt) * | 2000-07-07 | 2003-06-24 | Tufts College | Compostos de tetraciclina substituìda, e de sanciclina 7-substituìda, método para tratar um estado responsivo à tetraciclina em um indivìduo, e, composição farmacêutica |
SI1301467T1 (sl) * | 2000-07-07 | 2007-02-28 | Tufts College | 9-substituirane minociklinske spojine |
MXPA03008165A (es) * | 2001-03-13 | 2003-12-12 | Paratek Pharm Innc | Compuestos tetraciclina sustituidos en la posicion 7,9. |
WO2002072022A2 (en) * | 2001-03-14 | 2002-09-19 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds as antifungal agents |
EP1408987B1 (en) * | 2001-07-13 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
AU2003235759A1 (en) * | 2002-01-08 | 2003-07-24 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
US6958161B2 (en) * | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
CN1700922A (zh) * | 2002-07-12 | 2005-11-23 | 帕拉特克药品公司 | 3、10或12a位取代的四环素化合物 |
WO2004017925A2 (en) * | 2002-08-23 | 2004-03-04 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
JP2006501310A (ja) * | 2002-08-29 | 2006-01-12 | アクティブバイオティクス インコーポレイティッド | クロストリジウム・ディフィシレの感染およびそれに関係する疾患を治療するための方法および試薬 |
US20050148553A1 (en) * | 2003-09-05 | 2005-07-07 | Testa Raymond T. | Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
GB2414668B (en) * | 2004-06-03 | 2009-07-29 | Dexcel Ltd | Tetracycline modified release delivery system |
-
2006
- 2006-12-20 BR BRPI0620646-8A patent/BRPI0620646A2/pt not_active Application Discontinuation
- 2006-12-20 KR KR1020087017661A patent/KR20080080205A/ko not_active Application Discontinuation
- 2006-12-20 EP EP06847833A patent/EP1965770A2/en not_active Withdrawn
- 2006-12-20 RU RU2008120672/15A patent/RU2008120672A/ru not_active Application Discontinuation
- 2006-12-20 CN CNA2006800482101A patent/CN101340895A/zh active Pending
- 2006-12-20 WO PCT/US2006/048621 patent/WO2007075794A2/en active Application Filing
- 2006-12-20 CA CA002632213A patent/CA2632213A1/en not_active Abandoned
- 2006-12-20 AU AU2006331688A patent/AU2006331688A1/en not_active Abandoned
- 2006-12-21 US US11/642,509 patent/US20080014256A1/en not_active Abandoned
-
2008
- 2008-05-28 IL IL191789A patent/IL191789A0/en unknown
- 2008-05-30 NO NO20082547A patent/NO20082547L/no unknown
- 2008-06-17 GT GT200800107A patent/GT200800107A/es unknown
- 2008-06-27 CR CR10124A patent/CR10124A/es not_active Application Discontinuation
- 2008-07-18 EC EC2008008635A patent/ECSP088635A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1965770A2 (en) | 2008-09-10 |
CA2632213A1 (en) | 2007-07-05 |
GT200800107A (es) | 2008-11-19 |
AU2006331688A1 (en) | 2007-07-05 |
WO2007075794A2 (en) | 2007-07-05 |
RU2008120672A (ru) | 2010-01-27 |
WO2007075794A3 (en) | 2007-08-16 |
ECSP088635A (es) | 2008-08-29 |
CR10124A (es) | 2008-09-23 |
KR20080080205A (ko) | 2008-09-02 |
IL191789A0 (en) | 2008-12-29 |
BRPI0620646A2 (pt) | 2011-11-22 |
US20080014256A1 (en) | 2008-01-17 |
CN101340895A (zh) | 2009-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20082547L (no) | Orale formuleringer omfattende tigecycline | |
NO20092611L (no) | Krystallinsk faststoff Rasagilin base | |
NO20052306D0 (no) | Dispergerbare farmasoytiske blandinger. | |
LTPA2018502I1 (lt) | Per burną vartojamos kladribino kompozicijos | |
DK3984528T3 (da) | Farmaceutiske sammensætninger, som omfatter nilotinib | |
WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
EA200802008A1 (ru) | Фармацевтические композиции | |
DK3219705T3 (da) | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid | |
NO20063393L (no) | Farmasoytiske preparater | |
NO20042807L (no) | Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser | |
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
NO20054329D0 (no) | Adamantanderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som innbefatter slike | |
CY1113594T1 (el) | Φουμαρικο αλας της (αλφα s, βητα r)-6-βρωμο-αλφα-[2-(διμεθυλαμινο)αιθυλ]-2-μεθοξυ-αλφα-1-ναφθαλινυλ-βητα-φαινυλ-3-κινολινοαιθανολης | |
DK1837019T3 (da) | Orale dispergerbare farmaceutiske sammensætninger | |
NO20060964L (no) | Farmasoytiske sammensetninger med midifisert frigjoring av modafinil | |
EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
DK1879580T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet | |
NO20063293L (no) | Farmasoytiske forbindelser | |
ECSP22040921A (es) | Composición farmacéutica que comprende selexipag | |
DK1879581T3 (da) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolin-derivater som lægemidler til behandling af infertilitet | |
ATE552832T1 (de) | Antidepressivum-propharmaka | |
TR200903014A1 (tr) | Oral yolla dağılan dimebolin bileşimleri. | |
CL2008000949A1 (es) | Compuestos derivados de 2,3-benzodiazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos psicoticos. | |
TR200903548A1 (tr) | Oral yolla dağılan emoksipin bileşimleri | |
BRPI0411820B8 (pt) | composição farmacêutica para administração parenteral, e seus usos |